ijerph-logo

Journal Browser

Journal Browser

Prevention and Management of Substance Use and Mental Health Issues in the Perinatal Period

Editor


E-Mail Website
Guest Editor
College of Medicine, Central Michigan University, Mount Pleasant, MI 48859, USA
Interests: mother-child health; pregnancy substance use; maternal mental health; early child health and development

Special Issue Information

Dear Colleagues,

A significant volume of research over the last several decades has identified adverse outcomes following substance use and mental health issues during pregnancy and the post partum period. Children born to women who use legal or illicit substances or misused prescription drugs during pregnancy are at increased risk for a multitude of health and developmental concerns. Similarly, pregnancy and post natal mental health issues are associated with poor maternal and child outcomes, with both substance use and mental health issues negatively impacting mother–child attachment and family functioning. Despite these findings, rates of substance use and poor mental health during the perinatal period remain high and are neither universally identified nor successfully managed. In order to reduce adverse outcomes and improve quality of life for the women and children affected by these issues, high-quality evidence is needed, identifying populations at risk and the best methods of identification, intervention, and even prevention. For this Special Issue, we invite the submission of papers that address this evidence gap, focusing on one or more of the following topics:

  1. Identifying risk and resilience factors for maternal substance use and/or mental health issues during the perinatal period, as well as risk and resilience factors for poor outcomes following these experiences.
  2. The development and evaluation of methods or systems to prevent substance use or mental health issues in pregnancy and post partum or methods to prevent adverse outcomes following exposure.
  3. The development and evaluation of methods or systems to identify women with, or at risk for, substance use or mental health issues during the perinatal period or children exposed to these factors.
  4. The development and evaluation of methods or interventions addressing substance use or mental health issues during the perinatal period or methods or interventions to address the resulting outcomes.

Clinical, health system-based, and population health-focused studies are welcome, including original studies and comprehensive reviews.

Prof. Dr. Beth Bailey
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pregnancy substance use
  • perinatal mental health
  • mental health screening
  • substance use screening
  • pregnancy intervention
  • mental health risk
  • substance use risk
  • in utero exposures
  • mother–child health
  • developmental outcomes

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 293 KB  
Article
Structural and Policy Determinants of Access to Medications for Opioid Use Disorder Among Pregnant People in U.S. Jails
by Maya Lakshman, Sitara Murali, Camille T. Kramer, Carolyn B. Sufrin and Rebecca L. Fix
Int. J. Environ. Res. Public Health 2026, 23(2), 149; https://doi.org/10.3390/ijerph23020149 - 24 Jan 2026
Viewed by 1091
Abstract
Pregnant people in U.S. jails experience high rates of opioid use disorder (OUD), yet access to medications for opioid use disorder (MOUD) remains inconsistent. This mixed-methods study examines how jail policies, treatment infrastructure, and political context shape MOUD provision for pregnant incarcerated individuals. [...] Read more.
Pregnant people in U.S. jails experience high rates of opioid use disorder (OUD), yet access to medications for opioid use disorder (MOUD) remains inconsistent. This mixed-methods study examines how jail policies, treatment infrastructure, and political context shape MOUD provision for pregnant incarcerated individuals. We conducted a secondary analysis of a national survey of 2885 U.S. jails (analytic sample = 836). Logistic regression models assessed associations between MOUD provision and telemedicine capacity, community MOUD availability, state Medicaid expansion, and 2020 presidential voting outcomes. Qualitative responses characterized barriers to care. Findings confirm that MOUD access for pregnant incarcerated individuals remains limited and structurally patterned. Fewer than half of jails continued methadone or buprenorphine for pregnant individuals already in treatment, and initiation was uncommon. MOUD provision was more likely in Democrat-won states, jails with telemedicine capacity, and jails located in communities with MOUD providers, while limited community availability reduced odds of provision. Qualitative themes highlighted restrictive jail policies, provider discretion, diversion concerns, and misconceptions regarding fetal harm. These findings underscore persistent structural barriers to evidence-based perinatal OUD treatment in carceral settings and highlight the importance of telemedicine expansion, community treatment capacity, and standardized correctional policies to advance perinatal health equity. Full article
Back to TopTop